Risk factors for cerebrovascular and cardiovascular diseases beyond age 75 years.
Globally, cardiovascular diseases (CVDs) are the number one cause of all mortalities. Of these deaths, 7.6 million are due to heart attacks, and 5.7 millions are due to stroke. The Vienna Transdanube Aging Study (VITA), a population-based cohort study, enabled us to evaluate associations between the known major risk factors for cerebrovascular and CVDs and their appearance beyond age 75 years. Using a single birth cohort, age was excluded as confounding factor. In the baseline investigations in the Danube Hospital, 606 individuals took part and were examined completely at baseline. After 60 months, 508 patients were re-examined. Each participant underwent an indepth investigation with the duration of 7 h, including neuropsychological testing, as well as analyses of biochemical, clinical chemical and genetic parameters, and magnetic resonance imaging (MRI) of the brain. In the present study, only a history of cerebral and cardiovascular events at the baseline or smoking was associated significantly with the appearance of CVDs. In a multiple model both risk factors-history of cerebral and cardiovascular events at the baseline (p = 0.0003, OR 2.36, 95% CI 1.49-3.76) and smoking (p = 0.0005, OR 1.57, 95% CI 1.22-2.03)-remained significant. However, the predictive value of this assessment model was low. The rescaled r² of the model was 0.088. A significant correlation was found only between exposure to cigarette smoke or a history of previous CVDs, such as stroke or myocardial infarction. Smoking or earlier CVDs greatly increase the risk for further cerebral and cardiovascular events in persons after 75 years.
Mostafaie
N
N
Department of Clinical Chemistry and Laboratory Medicine, Danube Hospital, Langobardenstr.122, 1220 Vienna, Austria. nazanin.mostafaie@wienkav.at
Huber
K R
KR
Sebesta
C
C
Krampla
W
W
Jungwirth
S
S
Zehetmayer
S
S
Hinterberger
M
M
Krugluger
W
W
Tragl
K H
KH
Fischer
P
P
D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology; D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000209:etiology*; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
Circulation. 1998 May 12;97(18):1837-47
9603539
N Engl J Med. 2008 Apr 3;358(14):1431-43
18376000
Immunol Today. 1997 Mar;18(3):111-5
9078682
JAMA. 1995 Jul 12;274(2):155-60
7596004
Clin Chem. 1972 Jun;18(6):499-502
4337382
Circulation. 1994 Jan;89(1):36-44
8281670
Am J Cardiol. 2002 Nov 1;90(9):927-31
12398956
Circulation. 1994 Dec;90(6):2905-8
7994837
Dement Geriatr Cogn Disord. 2008;25(6):501-7
18446027
Neurology. 2007 Jan 23;68(4):288-91
17242334
Clin Chem Lab Med. 2004;42(12):1430-3
15576307
Circulation. 2007 Feb 6;115(5):e69-171
17194875
Ann Intern Med. 1994 Mar 15;120(6):458-62
8311368
JAMA. 1988 Feb 19;259(7):1025-9
3339799
BMJ. 1989 Mar 25;298(6676):789-94
2496858
Stroke. 1995 Aug;26(8):1409-14
7631346
Arch Intern Med. 1994 Jun 13;154(11):1277-82
8203995
Am J Cardiol. 2007 Apr 1;99(7):970-3
17398194